Fidelity International’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,061
| Closed | -$70.5K | – | 904 |
|
|
2024
Q4 | $70.5K | Sell |
24,061
-99,818
| -81% | -$292K | ﹤0.01% | 862 |
|
|
2024
Q3 | $322K | Buy |
123,879
+3,906
| +3% | +$10.2K | ﹤0.01% | 812 |
|
|
2024
Q2 | $355K | Buy |
119,973
+54,893
| +84% | +$162K | ﹤0.01% | 777 |
|
|
2024
Q1 | $295K | Sell |
65,080
-1,810,792
| -97% | -$8.2M | ﹤0.01% | 785 |
|
|
2023
Q4 | $10.7M | Buy |
+1,875,872
| New | +$10.7M | 0.01% | 497 |
|
|
2023
Q2 | – | Sell |
-19,638
| Closed | -$148K | – | 804 |
|
|
2023
Q1 | $148K | Sell |
19,638
-1,518
| -7% | -$11.4K | ﹤0.01% | 763 |
|
|
2022
Q4 | $214K | Buy |
21,156
+1,718
| +9% | +$17.4K | ﹤0.01% | 767 |
|
|
2022
Q3 | $192K | Buy |
+19,438
| New | +$192K | ﹤0.01% | 770 |
|